Patents Assigned to BLUEROCK THERAPEUTICS LP
-
Publication number: 20250099331Abstract: A medical device system including a first container and a second container, the first container including a first container outer body defining a first interior space connected to a first opening of the first container; and a first container-side valve configured to be activated, upon connection of the second container to the first container, from a normally closed position into the first interior space to an activated position, and the second container including a second container outer body defining a second container interior space and a stem fluidly connected to the second container interior space, wherein, upon connection of the second container to the first container, the first container-side valve is configured to be brought into contact with the stem and the stem is configured to activate the first container-side valve from the normally closed position to the activated position.Type: ApplicationFiled: December 27, 2022Publication date: March 27, 2025Applicant: BLUEROCK THERAPEUTICS LPInventors: Peter ALDRIDGE, Philippe MARCHAND, Ibrahim DOMIAN, Anna M GALEA, Gregory POLLIERI, Angel Leonardo GUERRERO PALACIO, Brian MAC GIOLLA RI, Jonathan RUBIANTO, Matthew Gardner MAHER, Michael SCOTT
-
Publication number: 20240304008Abstract: A method for selecting a final model for detecting cells of interest in image datasets includes dividing a curated image dataset into a training set, a validation set, and a testing set where each image in the curated image dataset has been labeled as positive or negative for a cell of interest. The method trains each model of an ensemble of neural networks using the training and validation sets. Next, each model of the ensemble is tested using the testing set and the predictions of the ensemble are combined. The combined prediction is compared to the label and the method determines whether the combined prediction satisfies a pre-determined level of detection (LOD). If so, the method outputs the ensemble as a final ensemble. If not, the method modifies a hyperparameter of at least one of the models of the ensemble until the combined prediction satisfies the pre-determined LOD.Type: ApplicationFiled: April 15, 2024Publication date: September 12, 2024Applicant: BlueRock Therapeutics LPInventors: Dan Charles WILKINSON, Jr., Benjamin Adam BURNETT
-
Publication number: 20240209322Abstract: Provided herein are methods of obtaining induced pluripotent stem cells from cells of a hematopoietic lineage.Type: ApplicationFiled: March 25, 2022Publication date: June 27, 2024Applicant: BlueRock Therapeutics LPInventors: Peter D. TONGE, Borko TANASIJEVIC
-
Patent number: 11989960Abstract: A method for selecting a final model for detecting cells of interest in image datasets includes dividing a curated image dataset into a training set, a validation set, and a testing set where each image in the curated image dataset has been labeled as positive or negative for a cell of interest. The method trains each model of an ensemble of neural networks using the training and validation sets. Next, each model of the ensemble is tested using the testing set and the predictions of the ensemble are combined. The combined prediction is compared to the label and the method determines whether the combined prediction satisfies a pre-determined level of detection (LOD). If so, the method outputs the ensemble as a final ensemble. If not, the method modifies a hyperparameter of at least one of the models of the ensemble until the combined prediction satisfies the pre-determined LOD.Type: GrantFiled: February 20, 2020Date of Patent: May 21, 2024Assignee: BlueRock Therapeutics LPInventors: Dan Charles Wilkinson, Jr., Benjamin Adam Burnett
-
Publication number: 20240060047Abstract: Provided herein are genetically engineered mammalian (e.g., human) cells that express one or more transgenes at a sustained expression level. Also provided are methods of making and using the cells.Type: ApplicationFiled: October 9, 2020Publication date: February 22, 2024Applicant: BlueRock Therapeutics LPInventors: Chew-Li SOH, Mark James TOMISHIMA, Dan Charles WILKINSON, Jr., Conor Brian McAULIFFE
-
Publication number: 20230256177Abstract: In some embodiments, a delivery device includes a device actuator and a cannula portion through which a therapeutic substance is ejected. The cannula portion includes an outer shaft, a needle that is configured to move through the outer shaft, and a plunger that is configured to move through the needle, forming a positive displacement arrangement.Type: ApplicationFiled: April 26, 2023Publication date: August 17, 2023Applicant: BLUEROCK THERAPEUTICS LPInventors: MATTHEW GARDNER MAHER, ANGEL LEONARDO GUERRERO PALACIO, PHILIPPE MARCHAND
-
Patent number: 11666710Abstract: In some embodiments, a delivery device includes a device actuator and a cannula portion through which a therapeutic substance is ejected. The cannula portion includes an outer shaft, a needle that is configured to move through the outer shaft, and a plunger that is configured to move through the needle, forming a positive displacement arrangement.Type: GrantFiled: April 13, 2021Date of Patent: June 6, 2023Assignee: BLUEROCK THERAPEUTICS LPInventors: Matthew Gardner Maher, Angel Leonardo Guerrero Palacio, Philippe Marchand
-
Publication number: 20220306991Abstract: Provided herein are methods of obtaining induced pluripotent stem cells from cells of a hematopoietic lineage.Type: ApplicationFiled: March 25, 2022Publication date: September 29, 2022Applicant: BlueRock Therapeutics LPInventors: Peter D. Tonge, Borko Tanasijevic
-
Publication number: 20220228120Abstract: Provided herein are enriched populations of ventricular compact cardiomyocytes and enriched populations of mature ventricular or atrial cardiomyocytes, as well as methods of generating the enriched cell populations and methods of using the enriched cell populations in regenerative cardiac cell therapies.Type: ApplicationFiled: May 4, 2020Publication date: July 21, 2022Applicants: UNIVERSITY HEALTH NETWORK, BlueRock Therapeutics LPInventors: Gordon M. Keller, Shunsuke Funakoshi, lan Fernandes, Donghe Yang, Dan Charles Wilkinson, Jr.
-
Publication number: 20220172496Abstract: A method for selecting a final model for detecting cells of interest in image datasets includes dividing a curated image dataset into a training set, a validation set, and a testing set where each image in the curated image dataset has been labeled as positive or negative for a cell of interest. The method trains each model of an ensemble of neural networks using the training and validation sets. Next, each model of the ensemble is tested using the testing set and the predictions of the ensemble are combined. The combined prediction is compared to the label and the method determines whether the combined prediction satisfies a pre-determined level of detection (LOD). If so, the method outputs the ensemble as a final ensemble. If not, the method modifies a hyperparameter of at least one of the models of the ensemble until the combined prediction satisfies the pre-determined LOD.Type: ApplicationFiled: February 20, 2020Publication date: June 2, 2022Applicant: BlueRock Therapeutics LPInventors: Dan Charles WILKINSON, Jr., Benjamin Adam BURNETT
-
Publication number: 20210316081Abstract: In some embodiments, a delivery device includes a device actuator and a cannula portion through which a therapeutic substance is ejected. The cannula portion includes an outer shaft, a needle that is configured to move through the outer shaft, and a plunger that is configured to move through the needle, forming a positive displacement arrangement.Type: ApplicationFiled: April 13, 2021Publication date: October 14, 2021Applicant: BLUEROCK THERAPEUTICS LPInventors: MATTHEW GARDNER MAHER, ANGEL LEONARDO GUERRERO PALACIO, PHILIPPE MARCHAND